Ancestral characterization of the genomic landscape, comprehensive genomic profiling utilization, and treatment patterns may inform disparities in advanced prostate cancer: A large-scale analysis.

被引：9
|
作者：
Sivakumar, Smruthy
Lee, Jessica Kim
Moore, Jay A.
Hopkins, Julia
Newberg, Justin
Schrock, Alexa Betzig
Vince, Randy
Franco, Idalid Ivy
Seldon, Crystal Selesteen
Mills, Jennifer
Venstrom, Jeffrey Michael
Mahal, Brandon Arvin Virgil
机构：
[1] Fdn Med Inc, Cambridge, MA USA
[2] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA
[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] Harvard Radiat Oncol Program, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5003
引用
收藏
页数：3
相关论文
共 16 条
  • [1] Comprehensive genomic profiling and treatment patterns across ancestries in advanced prostate cancer: a large-scale retrospective analysis
    Sivakumar, Smruthy
    Lee, Jessica K.
    Moore, Jay A.
    Hopkins, Julia
    Newberg, Justin Y.
    Madison, Russell
    Graf, Ryon
    Schrock, Alexa B.
    Kobetz, Erin
    Vince, Randy
    Franco, Idalid
    Seldon, Crystal
    Frampton, Garrett M.
    Mills, Jennifer
    Venstrom, Jeffrey
    Mahal, Brandon A.
    LANCET DIGITAL HEALTH, 2023, 5 (06): : E380 - E389
  • [2] Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race
    Zimmerman, Raquel
    Bilen, Mehmet A.
    Heath, Elisabeth, I
    Nandagopal, Lakshminarayanan
    Swami, Umang
    Kessel, Adam
    Jaeger, Ellen
    Wesolowski, Sergiusz
    Hernanadez, Edgar J.
    Chipman, Jonathan
    Mack, Alleda
    Ravindranathan, Deepak
    Maughan, Benjamin L.
    Nussenzveig, Roberto
    Yandell, Mark
    Kohli, Manish
    Lilly, Michael B.
    Sartor, A. Oliver
    Agarwal, Neeraj
    Barata, Pedro C.
    ONCOLOGIST, 2022, 27 (10): : E815 - E818
  • [3] The landscape of NTRK fusions detected by comprehensive genomic profiling in patients with advanced cancer in a large healthcare system
    Ward, T.
    Piening, B.
    Stein, A.
    Eberhard, D.
    Weerasinghe, R.
    Dowdell, A.
    Bapat, B.
    Schroeder, B.
    Campbell, M.
    Bifulco, C.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S141 - S141
  • [4] The role of large-scale genomic analysis in the future of hereditary cancer treatment
    Momozawa, Yukihide
    CANCER SCIENCE, 2024, 115 : 824 - 824
  • [5] Large-Scale Cancer Genomic Analysis Reveals Significant Disparities between Microsatellite Instability and Tumor Mutational Burden
    Choi, Jungyoon
    Park, Kyong Hwa
    Kim, Yeul Hong
    Sa, Jason K.
    Sung, Hwa Jung
    Chen, Yu-Wei
    Chen, Zhishan
    Li, Chao
    Wen, Wanqing
    Zhang, Qingrun
    Shu, Xiao-ou
    Zheng, Wei
    Kim, Jung Sun
    Guo, Xingyi
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (05) : 712 - 720
  • [6] Large-scale cancer genomic analysis reveals significant disparities between microsatellite instability and tumor mutational burden
    Choi, Jungyoon
    Kim, Jung Sun
    Park, Kyong Hwa
    Guo, Xingyi
    Kim, Yeul Hong
    CANCER RESEARCH, 2023, 83 (07)
  • [7] Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling of cell-free DNA
    Swami, Umang
    Zimmerman, Raquel Mae
    Nussenzveig, Roberto H.
    Hernandez, Edgar Javier
    Jo, Yeonjung
    Sayegh, Nicolas
    Wesolowski, Sergiusz
    Kiedrowski, Lesli A.
    Barata, Pedro C.
    Lemmon, Gordon Howard
    Bilen, Mehmet A.
    Heath, Elisabeth I.
    Nandagopal, Lakshminarayan
    Babiker, Hani M.
    Pal, Sumanta K.
    Lilly, Michael
    Maughan, Benjamin L.
    Haaland, Benjamin
    Yandell, Mark
    Sartor, Oliver
    Agarwal, Neeraj
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling (CGP) of cell-free DNA (cfDNA)
    Reisinger, R.
    Swami, U.
    Hernandez, E. J.
    Sayegh, N.
    Wesolowski, S.
    Kiedrowski, L.
    Barata, P. M. Coelho
    Nussenzveig, R.
    Lemmon, G.
    Bilen, M. A.
    Heath, E.
    Nandagopal, L.
    Babiker, H.
    Pal, S. K.
    Lilly, M. B.
    Maughan, B. L.
    Yandell, M.
    Sartor, O.
    Agarwal, N.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1175 - S1175
  • [9] Differences in the tumor genomic landscape between African Americans (AA) and Caucasians (CA) advanced prostate cancer (aPC) patients (pts) by comprehensive genomic profiling (CGP) of cell-free DNA (cfDNA).
    Barata, Pedro C.
    Reisinger, Raquel
    Bilen, Mehmet Asim
    Heath, Elisabeth I.
    Nandagopal, Lakshminarayanan
    Swami, Umang
    Kessel, Adam
    Jaeger, Ellen
    Wesolowski, Sergiusz
    Chipman, Jonathan
    Mack, Alleda
    Ravindranathan, Deepak
    Maughan, Benjamin L.
    Nussenzveig, Roberto
    Yandell, Mark
    Kohli, Manish
    Lilly, Michael B.
    Sartor, A. Oliver
    Agarwal, Neeraj
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] Treatment Patterns and Survival of Patients With Advanced Non-Small Cell Lung Cancer Guided by Comprehensive Genomic Profiling: Real-World Single-Institute Study in China
    Lv, Weize
    Cheng, Hua
    Shao, Di
    Wei, Yajun
    Zhu, Weiping
    Wu, Kui
    Jiang, Wenxi
    Hu, Liyang
    Sha, Zhou
    Zhong, Beilong
    Pei, Xiaofeng
    FRONTIERS IN ONCOLOGY, 2021, 11
12